Zanfina Ademi
A5017617474- Health Systems, Economic Evaluations, Quality of Life
- Lipoproteins and Cardiovascular Health
- Pharmaceutical Economics and Policy
- Global Public Health Policies and Epidemiology
- Global Health Care Issues
- Heart Failure Treatment and Management
- Diabetes Treatment and Management
- Blood Pressure and Hypertension Studies
- Peripheral Artery Disease Management
- Healthcare Systems and Reforms
- Health disparities and outcomes
- Pharmaceutical Practices and Patient Outcomes
- Climate Change and Health Impacts
- Antiplatelet Therapy and Cardiovascular Diseases
- Medication Adherence and Compliance
- Total Knee Arthroplasty Outcomes
- Epilepsy research and treatment
- Cardiac Health and Mental Health
- Chronic Disease Management Strategies
- Pharmacological Effects and Toxicity Studies
- Health and Medical Research Impacts
- Coronary Interventions and Diagnostics
- Global Maternal and Child Health
- Cerebrovascular and Carotid Artery Diseases
- Child Nutrition and Water Access
Monash University
2016-2025
University of Eastern Finland
2007-2025
Finland University
2024
The University of Melbourne
2011-2023
The Royal Melbourne Hospital
2011-2023
Alfred Health
2020-2023
Florey Institute of Neuroscience and Mental Health
2020-2023
Austin Hospital
2020-2023
The Alfred Hospital
2007-2023
Monash Institute of Medical Research
2023
BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to factor quantification that offers useful tool for synthesising evidence on risks risk–outcome associations. With each annual GBD study, we update the CRA incorporate improved methods, new pairs, data exposure levels associations.MethodsWe used framework developed previous iterations estimate trends in exposure, attributable deaths,...
Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular all-cause mortality. Unlike other chronic diseases with established strategies for screening, there has been no consensus on whether health systems governments should prioritize early identification intervention CKD. Guidelines evaluating managing CKD are available but have not universally adopted in the absence of incentives or quality measures prioritizing care. The burden falls disproportionately...
A comprehensive understanding of temporal trends in the disease burden Australia is lacking, and these are required to inform health service planning improve population health. We explored diseases their risk factors from 1990 2019 through a analysis Global Burden Disease Study (GBD) 2019.In this systematic for GBD 2019, we estimated all-cause mortality using standardised methodology. Data sources included primarily vital registration systems with additional data sample registrations,...
Hypertension increases the risk of premature death and reduces work productivity. We estimated burden hypertension in Australia terms productivity lost over working lifetime Australian population. Life table models were used to estimate excess mortality, years life lost, productivity-adjusted among Australians with age (20 69 years), simulated follow-up until 70 years. In 2017, an 4.1 million working-age (25.9%) had hypertension, whom 21.6% treated controlled, 17.0% but uncontrolled, 61.4%...
To estimate the health and economic burden of new established cardiovascular disease from 2020 to 2029 in Australia.A two-stage multistate dynamic model was developed predict incident prevalent disease, for Australians 40-90 years old 2029. The captured morbidity, mortality, life lived, quality-adjusted years, healthcare costs, productivity losses. Cardiovascular risk primary prevention population derived using Australian demographic data Pooled Cohort Equation. Risk secondary REACH...
Importance The Netherlands is one of the few countries that has a long-term history active screening for familial hypercholesterolemia (FH), enabling health-economic analyses. Objective To investigate cost-effectiveness and return on investment (ROI) nationwide cascade case-finding preventive treatment program starting with identification FH in children treatment, from both societal health care perspective. Design, Setting, Participants Cascade early were modeled to simulate progression...
No population-based studies have investigated how the impact of hip and knee joint disease may vary with increasing severity.The purpose this study was to evaluate health-related quality life (HRQoL), work status, health service utilization costs according severity disease.A national cross-sectional survey conducted.Five thousand individuals were randomly selected from Australian electoral roll invited complete a questionnaire screen for doctor-diagnosed arthritis, osteoarthritis (OA), OA....